State Rep. Jim Struzzi, R-Indiana, announced Wednesday that the House Health Committee has passed two resolutions he authored. House Resolution 459 would request guidelines for the commercial sale of CBD products from the Food and Drug Administration. House Resolution 460 would request guidance and appropriate protocol from the FDA for the safe use of Kratom.
“The affects of these products are still relatively unknown. Without oversight from the FDA, there is a lack of consistency in the market. This leads to retailers not being fully knowledgeable about the products they sell, and consumers not being fully knowledgeable about the products they purchase,” Struzzi said in a news release. “My resolutions would go a long way in providing clear guidelines for the sale and use of these products so retailers and consumers know they are being safe and responsible.”